mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.0055 |
0.9 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.38 |
2e-22 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.36 |
8e-22 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
2e-15 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
1e-13 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
8e-13 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-12 |